Maryland State Retirement & Pension System’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-47,110
Closed -$209K 1480
2024
Q4
$209K Sell
47,110
-1,661
-3% -$6.74K ﹤0.01% 1475
2024
Q3
$201K Hold
48,771
﹤0.01% 1497
2024
Q2
$318K Sell
48,771
-1,164
-2% -$8.23K 0.01% 1366
2024
Q1
$382K Hold
49,935
0.01% 1264
2023
Q4
$571K Sell
49,935
-639
-1% -$6.32K 0.01% 1049
2023
Q3
$487K Sell
50,574
-2,081
-4% -$20.4K 0.01% 1075
2023
Q2
$560K Sell
52,655
-1,088
-2% -$11.7K 0.01% 1018
2023
Q1
$565K Sell
53,743
-1,372
-2% -$15.4K 0.01% 959
2022
Q4
$683K Buy
+55,115
New +$625K 0.02% 769
2022
Q3
Sell
-62,338
Closed -$719K 736
2022
Q2
$719K Buy
+62,338
New +$734K 0.02% 693

Other funds holding IRWD

Maryland State Retirement & Pension System's IRWD Position: Q1 2025 in Review

Maryland State Retirement & Pension System sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2025, closing a stake of 47,110 shares — an estimated $209K sold.

Maryland State Retirement & Pension System first reported a position in IRWD in Q2 2022 and held it in 10 quarters. The position peaked at $719K in Q2 2022. 200 funds tracked by Wall St. Rank hold IRWD as of Q1 2025.

  • Maryland State Retirement & Pension System reported no remaining Ironwood Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Maryland State Retirement & Pension System sold 47,110 Ironwood Pharmaceuticals shares in Q1 2025, an estimated $209K.
  • Maryland State Retirement & Pension System first reported a position in Ironwood Pharmaceuticals in Q2 2022 and held it in 10 quarters.
  • Maryland State Retirement & Pension System's Ironwood Pharmaceuticals position peaked at $719K in Q2 2022.
  • 200 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2025.

Based on Maryland State Retirement & Pension System's 13F filing for Q1 2025, filed 12 May 2025.